U.S. markets closed
  • S&P Futures

    4,201.75
    -21.25 (-0.50%)
     
  • Dow Futures

    33,869.00
    -148.00 (-0.44%)
     
  • Nasdaq Futures

    13,880.50
    -100.75 (-0.72%)
     
  • Russell 2000 Futures

    2,294.50
    -15.60 (-0.68%)
     
  • Crude Oil

    71.64
    -0.51 (-0.71%)
     
  • Gold

    1,819.60
    -41.80 (-2.25%)
     
  • Silver

    27.23
    -0.58 (-2.09%)
     
  • EUR/USD

    1.1989
    -0.0012 (-0.10%)
     
  • 10-Yr Bond

    1.5690
    +0.0700 (+4.67%)
     
  • Vix

    18.15
    +1.13 (+6.64%)
     
  • GBP/USD

    1.3976
    -0.0011 (-0.08%)
     
  • USD/JPY

    110.8000
    +0.1870 (+0.17%)
     
  • BTC-USD

    38,543.27
    -1,594.18 (-3.97%)
     
  • CMC Crypto 200

    955.26
    -37.21 (-3.75%)
     
  • FTSE 100

    7,184.95
    +12.47 (+0.17%)
     
  • Nikkei 225

    29,149.34
    -141.67 (-0.48%)
     

If You Had Bought Optiscan Imaging (ASX:OIL) Shares Five Years Ago You'd Have Earned 253% Returns

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can make more than 100%. For instance, the price of Optiscan Imaging Limited (ASX:OIL) stock is up an impressive 253% over the last five years. Also pleasing for shareholders was the 76% gain in the last three months.

Check out our latest analysis for Optiscan Imaging

Optiscan Imaging wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

In the last 5 years Optiscan Imaging saw its revenue grow at 31% per year. That's well above most pre-profit companies. Meanwhile, its share price performance certainly reflects the strong growth, given the share price grew at 29% per year, compound, during the period. So it seems likely that buyers have paid attention to the strong revenue growth. To our minds that makes Optiscan Imaging worth investigating - it may have its best days ahead.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

A Different Perspective

We're pleased to report that Optiscan Imaging shareholders have received a total shareholder return of 208% over one year. That's better than the annualised return of 29% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 5 warning signs for Optiscan Imaging you should be aware of, and 1 of them is concerning.

Of course Optiscan Imaging may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on AU exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.